Elena Andreeva

Dr. Elena Andreeva


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2014 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
EAElena Andreeva
Elena Andreeva
HMHasse Melbye
Hasse Melbye
Point of care testing for C-reactive protein (CRP) has shown promise as a measure to reduce unnecessary antibiotic prescribing in respiratory tract infections (RTI), but its use in primary care is still controversial. We aimed to evaluate the effect of CRP testing on the prescription of antibiotics, referral for radiography, and the outcome of patients in general practice with acute cough/RTI.

23 June 2017 in npj Primary Care Respiratory Medicine
Verified
Journal Article
Open access
PDF file
EEEva Anne Marije van Eerd
Eva Anne Marije van Eerd
MRMette Bech Risør
Mette Bech Risør
MSMark Spigt
Mark Spigt
MGMaciek Godycki-Cwirko
Maciek Godycki-Cwirko
EAElena Andreeva
Elena Andreeva
DKDaniel Kotz
Daniel Kotz
Smoking cessation is the only effective intervention to slow down the accelerated decline in lung function in smokers with chronic obstructive pulmonary disease. Nevertheless, physicians often do not routinely provide evidence-based smoking cessation treatment to their patients. To understand underlying reasons, we explored how physicians engage in smoking cessation treatment in their chronic obstructive pulmonary disease patients. In total, 21 focus group discussions were held with general practitioners and pulmonologists in seven different countries in Europe and Asia. We generated three themes, whereby some of the issues concerned smokers in general: first, ‘physicians’ frustration with chronic obstructive pulmonary disease patients who smoke’. These frustrations interfered with the provision of evidence-based treatment and could result in this group of patients being treated unequally. Second: ‘physicians’ limited knowledge of, and negative beliefs about, smoking cessation treatment’. This hindered treating smokers effectively. Third: ‘healthcare organisational factors that influence the use of smoking cessation treatments’. Money and time issues, as well as the failure to regard smoking as a disease, influenced how physicians engaged in smoking cessation treatment. Our results indicate that there is a number of barriers to the provision of effective smoking cessation treatment in patients with chronic obstructive pulmonary disease and smokers in general. Introducing an informative smoking cessation programme, including communication skills and ethical issues, in the vocational and postgraduate medical training may help to address these barriers. This is important in order to increase engagement with smoking cessation treatment and to improve quality of chronic obstructive pulmonary disease care.

14 November 2017 in npj Primary Care Respiratory Medicine
Verified
Journal Article
Open access
PDF file
EAElena Andreeva
Elena Andreeva
MPMarina Pokhaznikova
Marina Pokhaznikova
ALAnatoly Lebedev
Anatoly Lebedev
IMIrina Moiseeva
Irina Moiseeva
OKOlga Kuznetsova
Olga Kuznetsova
JDJean-Marie Degryse
Jean-Marie Degryse
A hallmark of the diagnosis of chronic obstructive pulmonary disease (COPD) is the measurement of post-bronchodilator (post-BD) airflow obstruction (AO) by spirometry, but spirometry is not enough for the provision of a clinical diagnosis. In the majority of previous epidemiological studies, COPD diagnosis has been based on spirometry and a few clinical characteristics. The aim of our study was to identify outcomes in patients newly diagnosed with airflow obstruction (AO) based on a diagnostic work-up conducted as part of a population-based cross-sectional study in North-Western Russia. Spirometry was performed before (pre-BD) and after BD administration, and AO was defined using the FEV1/FVC <0.70 and FEV1/FVC <lower limit of normal cut-off values. Relevant symptoms were recorded. Participants with AO identified at baseline were then examined by a pulmonologist, including a clinical examination and second spirometry with BD test. Of the 102 participants with post-BD AO in the initial assessment, only 60.8% still had AO identified at the second examination; among these patients, the following final diagnoses were reported: COPD (n = 41), asthma (n = 5), asthma–COPD overlap syndrome (ACOS) (n = 4) and likely ACOS (n = 5). Of the 65 participants with pre-BD AO, 23.1% had post-BD AO at the second assessment, and these patients had been diagnosed with COPD (n = 12), asthma (n = 1), ACOS (n = 1), likely ACOS (n = 1). Serial spirometric assessments complemented by a comprehensive clinical evaluation are recommended in new epidemiological studies.

1 January 2016 in Respiration
Verified
Journal Article
Closed access
EAElena Andreeva
Elena Andreeva
MPMarina Pokhaznikova
Marina Pokhaznikova
ALAnatoly Lebedev
Anatoly Lebedev
IMIrina Moiseeva
Irina Moiseeva
OKOlga Kutznetsova
Olga Kutznetsova
JDJean-Marie Degryse
Jean-Marie Degryse
Background: The prevalence of chronic obstructive pulmonary disease (COPD) varies in different countries, while the cut-off for airflow obstruction (AO) is still contested. No COPD prevalence data based on the Global Lung Initiative (GLI) 2012 equations are available in Russia. Objectives: This study aims to assess AO prevalence by the GLI lower limit of normal (GLI-LLN) and the fixed cut-off, to identify AO risk factors and to assess the diagnostic value of respiratory symptoms in north-western Russia. Methods: In a north-western Russian population-based sample of 2,974 adults aged 35-70 years, data on socio-demographics, smoking, occupational exposures and respiratory symptoms were collected, and spirometry was performed before and after bronchodilator (BD) administration. Results: The AO prevalence was 6.8% (95% CI 5.8-7.9) based on the fixed and 4.8% (95% CI 3.9-5.7) based on the GLI-LLN cut-off. 22.5% of the participants with post-BD AO had a positive bronchodilator test, and 1% showed a paradoxical BD response. Of the environmental factors studied, only smoking was independently associated with AO (odds ratio 2.47, 95% CI 1.60-3.82). The positive predictive value of respiratory symptoms for AO was 11% based on the fixed and 8% based on the GLI-LLN cut-off. Conclusions: In a sample of adults in north-western Russia, the AO prevalence by the GLI-LLN cut-off was lower than that by the fixed cut-off. The predictive value of respiratory symptoms was low.

1 February 2017 in Journal of the American Medical Directors Association
Verified
Journal Article
Closed access
EHEralda Hegendörfer
Eralda Hegendörfer
BVBert Vaes
Bert Vaes
EAElena Andreeva
Elena Andreeva
CMCatharina Matheï
Catharina Matheï
GPGijs Van Pottelbergh
Gijs Van Pottelbergh
JDJean-Marie Degryse
Jean-Marie Degryse

25 February 2015 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
ETEralda Turkeshi
Eralda Turkeshi
BVBert Vaes
Bert Vaes
EAElena Andreeva
Elena Andreeva
CMCatharina Matheï
Catharina Matheï
WAWim Adriaensen
Wim Adriaensen
JDJean-Marie Degryse
Jean-Marie Degryse
Spirometry-based parameters of pulmonary function such as forced expiratory volume in 1 second (FEV1) have prognostic value beyond respiratory morbidity and mortality. FEV1 divided by height cubed (FEV1/Ht3) has been found to be better at predicting all-cause mortality than the usual standardization as percentage of predicted